118 related articles for article (PubMed ID: 12897821)
21. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
[TBL] [Abstract][Full Text] [Related]
22. Pressure alters endothelial effects upon vascular smooth muscle cells by decreasing smooth muscle cell proliferation and increasing smooth muscle cell apoptosis.
Vouyouka AG; Jiang Y; Basson MD
Surgery; 2004 Aug; 136(2):282-90. PubMed ID: 15300192
[TBL] [Abstract][Full Text] [Related]
23. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
[TBL] [Abstract][Full Text] [Related]
24. Effects of S-dC28 on vascular smooth muscle cell adhesion and plasminogen activator production.
Wang W; Chen HJ; Warshofsky M; Schwartz A; Stein CA; Rabbani LE
Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):101-7. PubMed ID: 9149845
[TBL] [Abstract][Full Text] [Related]
25. Ethanol inhibits basal and flow-induced vascular smooth muscle cell migration in vitro.
Hendrickson RJ; Okada SS; Cahill PA; Yankah E; Sitzmann JV; Redmond EM
J Surg Res; 1999 Jun; 84(1):64-70. PubMed ID: 10334891
[TBL] [Abstract][Full Text] [Related]
26. The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation.
El Fahime E; Mills P; Lafreniere JF; Torrente Y; Tremblay JP
Exp Cell Res; 2002 Nov; 280(2):169-78. PubMed ID: 12413883
[TBL] [Abstract][Full Text] [Related]
27. Receptor-bound uPA is reversibly protected from inhibition by low molecular weight inhibitors.
Dyer KD; Linz-Mcgillem LA; Alliegro MA; Alliegro MC
Cell Biol Int; 2002; 26(4):327-35. PubMed ID: 11991662
[TBL] [Abstract][Full Text] [Related]
28. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological Inhibition of Vanin Activity Attenuates Transplant Vasculopathy in Rat Aortic Allografts.
Wedel J; Jansen PA; Botman PN; Rutjes FP; Schalkwijk J; Hillebrands JL
Transplantation; 2016 Aug; 100(8):1656-66. PubMed ID: 27014792
[TBL] [Abstract][Full Text] [Related]
30. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
Cullen JP; Nicholl SM; Sayeed S; Sitzmann JV; Okada SS; Cahill PA; Redmond EM
Thromb Res; 2004; 114(1):57-65. PubMed ID: 15262486
[TBL] [Abstract][Full Text] [Related]
31. Intracellular calcium transients are necessary for platelet-derived growth factor but not extracellular matrix protein-induced vascular smooth muscle cell migration.
Hollenbeck ST; Nelson PR; Yamamura S; Faries PL; Liu B; Kent KC
J Vasc Surg; 2004 Aug; 40(2):351-8. PubMed ID: 15297833
[TBL] [Abstract][Full Text] [Related]
32. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
Kiyan J; Haller H; Dumler I
Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
[TBL] [Abstract][Full Text] [Related]
34. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
35. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation.
Xiaoli M; Wenying H; Mingpeng S
Int J Cardiol; 1998 Oct; 66 Suppl 1():S57-64; discussion S65. PubMed ID: 9951803
[TBL] [Abstract][Full Text] [Related]
36. [Tanshinone II A inhibits in vitro cellular proliferation and migration of vascular smooth muscle cell of rabbit].
Zhang HH; Chen YC; Liang L; Zeng Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):188-92. PubMed ID: 18630680
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of PHGPx inhibits hydroperoxide-induced oxidation, NFkappaB activation and apoptosis and affects oxLDL-mediated proliferation of rabbit aortic smooth muscle cells.
Brigelius-Flohé R; Maurer S; Lötzer K; Böl G; Kallionpää H; Lehtolainen P; Viita H; Ylä-Herttuala S
Atherosclerosis; 2000 Oct; 152(2):307-16. PubMed ID: 10998458
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis.
Poussier B; Cordova AC; Becquemin JP; Sumpio BE
J Vasc Surg; 2005 Dec; 42(6):1190-7. PubMed ID: 16376213
[TBL] [Abstract][Full Text] [Related]
39. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
Jankun J; Skrzypczak-Jankun E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
[TBL] [Abstract][Full Text] [Related]
40. Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation.
Galaria II; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2005 Jul; 127(1):46-52. PubMed ID: 15964303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
